Gonorrhoea: a Systematic Review of Prevalence Reporting Globally
Overview
Affiliations
Background: The World Health Organization (WHO) recommends periodic gonorrhoea prevalence assessments in the general population or proxies thereof (including pregnant women, women attending family planning clinics, military recruits, and men undergoing employment physicals for example) and in population groups at increased risk, including men-who-have-sex-with-men (MSM) and sex workers.
Method: We evaluated reported prevalence data, including estimates from proxy general population samples to reflect the WHO recommendations. We describe the outcomes from the general population country-by-country and extend previous reviews to include MSM, sex workers, and extragenital infections.
Result And Conclusion: In our systematic search, 2015 titles were reviewed (January 2010-April 2019) and 174 full-text publications were included. National, population-based prevalence data were identified in only four countries (the United States of America, the United Kingdom, Peru, New Caledonia) and local population-based estimates were reported in areas within five countries (China, South Africa, Brazil, Benin, and Malawi). The remaining studies identified only reported test positivity from non-probability, proxy general population samples. Due to the diversity of the reviewed studies, detailed comparison across studies was not possible. In MSM, data were identified from 64 studies in 25 countries. Rectal infection rates were generally higher than urogenital or pharyngeal infection rates, where extragenital testing was conducted. Data on sex workers were identified from 41 studies in 23 countries; rates in female sex workers were high. Current prevalence monitoring was shown to be highly suboptimal worldwide. Serial prevalence monitoring of critical epidemiological variables, and guidelines to optimize prevalence study conduct and reporting beyond antenatal settings are recommended.
Michalow J, Hall L, Rowley J, Anderson R, Hayre Q, Chico R medRxiv. 2025; .
PMID: 39763549 PMC: 11702751. DOI: 10.1101/2024.12.16.24319070.
Allan-Blitz L, Adams G, Sanders G, Shah P, Ramesh K, Jarolimova J mSphere. 2024; 10(1):e0067724.
PMID: 39688405 PMC: 11774021. DOI: 10.1128/msphere.00677-24.
Llangari-Arizo L, Broad C, Zhou L, Martin Mateo M, Moreno C, Moreno Cevallos M Sex Transm Infect. 2024; 100(8):504-511.
PMID: 39117400 PMC: 11672068. DOI: 10.1136/sextrans-2023-056075.
Global trends of antimicrobial resistance rates in : a systematic review and meta-analysis.
Hosseini Hooshiar M, Sholeh M, Beig M, Azizian K, Kouhsari E Front Pharmacol. 2024; 15:1284665.
PMID: 39035993 PMC: 11258497. DOI: 10.3389/fphar.2024.1284665.
Gonorrhea cluster detection in Manitoba, Canada: Spatial, temporal, and spatio-temporal analysis.
Abed A, Torabi M, Mashreghi Z Infect Dis Model. 2024; 9(4):1045-1056.
PMID: 38974897 PMC: 11222937. DOI: 10.1016/j.idm.2024.05.009.